Epigenomics Forecast, price target & analysts
Epigenomics Target price 2024 - Analyst rating & recommendation
Epigenomics Classifications & Recommendation:
Epigenomics Target price
| Target price | €17.90 |
| Course | €0.70 |
| Price potential |
2,457.14%
register free of charge
|
| Number of estimates | 1 |
|
1 Analyst has issued a Epigenomics price target 2025.
The average Epigenomics target price is €17.90.
This is
2,457.14%
register free of charge
|
|
| A rating was issued by 1 analysts: 1 Analysts recommend Epigenomics to buy, 0 to hold and 0 to sell. | |
| Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis. | |
|
Analyst estimates: Analysts believe that the Epigenomics share has an average upside potential 2025 of
2,457.14%
register free of charge
|
Sales and margin forecast 2023, 2024 & 2025
| Dec '22 |
2023 Forecast |
|
|---|---|---|
| Turnover Million € | 0.49 | 0.90 |
| 92.10% | 84.18% | |
| EBITDA margin | -2,489.80% | -647.92% |
| 3,868.31% | 73.98% | |
| Net margin | -2,563.88% | -803.16% |
| 21,395.66% | 68.67% |
2 Analysts have issued a sales forecast Epigenomics 2023 . The average Epigenomics sales estimate is
This results in the following potential growth figures:
2 Analysts have issued an Epigenomics EBITDA forecast 2023. The average Epigenomics EBITDA estimate is
This results in the following potential growth figures and future EBITDA margins:
2 Epigenomics Analysts have issued a net profit forecast 2023. The average Epigenomics net profit estimate is
This results in the following potential growth figures and future net margins:
Earnings per share, P/E ratio and EV/sales forecast 2023, 2024 & 2025
| Dec '22 |
2023 Forecast |
|
|---|---|---|
| Earnings per share € | -14.78 | -8.53 |
| 1,598.85% | 42.29% | |
| P/E ratio | negative | |
| EV/Sales | negative |
2 Analysts have issued a Epigenomics forecast for earnings per share. The average Epigenomics <a href=/blog/eps>EPS is
This results in the following potential growth figures and future valuations:
Based on analysts' sales estimates for 2023, the Epigenomics share is valued at an <a href=/blog/ev-sales-einfach-erklaert>EV/Sales of
This results in the following potential growth figures and future valuations:
Discover more stocks with a high price target
Register for Free
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.
